Evidence map›Paper›PMID 41727412›Full record

ArticleJAMIA open2026

Enhancing cause of death prediction: development and validation of machine learning models using multimodal data across multiple health-care sites.

Mohammed Al-Garadi, Rishi J Desai, Kerry Ngan, Michele LeNoue-Newton, Ruth M Reeves, Daniel Park, Jose J Hernández-Muñoz, Shirley V Wang, Judith C Maro, Candace C Fuller and 10 more

Abstract read
In one paragraph

Article in JAMIA open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Mohammed Al-GaradiDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.
Rishi J DesaiDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, United States.
Kerry NganDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, United States.
Michele LeNoue-NewtonDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.ORCID https://orcid.org/0000-0003-3469-3784
Ruth M ReevesDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.
Daniel ParkDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.
Jose J Hernández-MuñozOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, United States.ORCID https://orcid.org/0000-0002-2553-3159
Shirley V WangDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, United States.ORCID https://orcid.org/0000-0001-7761-7090
Judith C MaroHarvard Pilgrim Health Care Institute and Department of Population Medicine, Harvard Medical School, Boston, MA 02215, United States.
Candace C FullerHarvard Pilgrim Health Care Institute and Department of Population Medicine, Harvard Medical School, Boston, MA 02215, United States.
Joshua Lin KueiyuDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, United States.
Aida KuzucanOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, United States.
Kevin CoughlinHarvard Pilgrim Health Care Institute and Department of Population Medicine, Harvard Medical School, Boston, MA 02215, United States.
Haritha PillaiDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, United States.
Melissa McPheetersRTI International, Research Triangle Park, NC 27709, United States.
Jill WhitakerDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.
Jessica A BucknerDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.
Michael F McLemoreDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.
Dax M WestermanDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.
Michael E MathenyDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To develop and validate machine learning (ML) models that predict probable cause of death (CoD) using structured electronic health record (EHR) data, unstructured clinical notes, and publicly available sources. Materials and Methods: This multi-institutional retrospective study was conducted across Vanderbilt University Medical Center (VUMC) and Massachusetts General Brigham (MGB), including deceased patients with encounters between October 1, 2015, and January 1, 2021, and confirmed death records. The cohort included 13 708 patients from VUMC and 34 839 from MGB.The primary outcome was underlying CoD categorized into the top 15 National Center for Health Statistics rankable causes, with others grouped as "Other." Performance was assessed using weighted area under the receiver operating characteristic curve (AUC) and F-measure. Results: The XGBoost model using structured EHR data alone achieved weighted AUCs of 0.86 (95% CI, 0.84-0.88) at VUMC and 0.80 (95% CI, 0.79-0.80) at MGB. Adding unstructured notes improved performance, with weighted AUCs of 0.90 (95% CI, 0.88-0.93) at VUMC and 0.92 (95% CI, 0.91-0.92) at MGB. Adding publicly available data did not further improve performance. Cross-institutional validation revealed significant performance degradation. Discussion: Models integrating structured and unstructured EHR data show strong within-institution performance but limited generalizability across healthcare systems, highlighting challenges related to institutional data heterogeneity. Conclusions: Machine learning models combining structured and unstructured EHR data accurately predict CoD within institutions but perform poorly across sites. Health-care institutions may benefit from adopting robust processes for locally tailored models, and future research should focus on enhancing model generalizability while addressing unique institutional data environments.

Indexed as

cause of death predictionclinical notescross-site validationelectronic health recordslarge language modelsmachine learningmortality surveillancestructured dataunstructured data

Identifiers

PMID41727412
PMCPMC12924636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.